HFS
IPCI

HL Financial Services’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

HL Financial Services’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,300
Closed -$69K – 710
2017
Q2 		$69K Hold
3,300
– – ﹤0.01% 668
2017
Q1 		$83K Hold
3,300
– – ﹤0.01% 650
2016
Q4 		$94K Buy
+3,300
New +$92.2K ﹤0.01% 657

Other funds holding IPCI

FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VAM
Verity Asset Management Durham, North Carolina $238M AUM 24.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HL Financial Services's IPCI Position: Q3 2017 in Review

HL Financial Services sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2017, closing a stake of 3,300 shares — an estimated $69K sold.

HL Financial Services first reported a position in IPCI in Q4 2016 and held it in 3 quarters. The position peaked at $94K in Q4 2016. 24 funds tracked by Wall St. Rank hold IPCI as of Q3 2017.

  • HL Financial Services reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2017 after selling out during the quarter.
  • HL Financial Services sold 3,300 Intellipharmaceuticals International Inc. shares in Q3 2017, an estimated $69K.
  • HL Financial Services first reported a position in Intellipharmaceuticals International Inc. in Q4 2016 and held it in 3 quarters.
  • HL Financial Services's Intellipharmaceuticals International Inc. position peaked at $94K in Q4 2016.
  • 24 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2017.

Based on HL Financial Services's 13F filing for Q3 2017, filed 3 Nov 2017.